Bengaluru, July 17, 2025 – Anthem Biosciences, a leading biopharmaceutical company, finalized its IPO allotment status today, July 17, 2025. The company’s initial public offering (IPO) opened for subscription on July 14, 2025, and closed on July 16, 2025. Investors eagerly awaited the allotment results. They can now check their application status online.
The IPO received a strong response. Over 5 million applications were submitted. The share applications were oversubscribed by 12 times. This shows high demand for Anthem Biosciences’ shares. The company offered 2 crore equity shares. The price band was ₹450 to ₹475 per share. Retail investors needed to apply for a minimum of 30 shares.
To check the allotment status, investors can visit the registrar’s website, Link Intime India. They need their application number or PAN details. Alternatively, they can use the BSE website (www.bseindia.com) or NSE website (www.nseindia.com). Steps include selecting the IPO name and entering the required details. The process is simple and user-friendly.
Anthem Biosciences will credit shares to successful applicants’ demat accounts by July 20, 2025. Refunds for unsuccessful applicants will also start on the same day. The company plans to list its shares on BSE and NSE on July 22, 2025. This IPO marks a significant milestone for Anthem Biosciences. It strengthens its position in the biopharma sector.
